Aim: Accumulation of α-synuclein (α-syn) in the brain is a characteristic of Parkinson's disease (PD). In this study, we investigated whether treatment with tunicamycin, an endoplasmic reticulum (ER) stress inducer, led to the accumulation of α-syn in PC12 cells, and where α-syn protein was accumulated, and finally, whether bibenzyl compound 20c, a novel compound isolated from Gastrodia elata (Tian ma), could alleviate the accumulation of α-syn and ER stress activation in tunicamycin-treated PC12 cells. Methods: PC12 cells were treated with tunicamycin for different time (6 h, 12 h, 24 h, 48 h). Cell viability was determined by a MTT assay. Subcellular fractions of ER and mitochondria were extracted with the Tissue Endoplasmic reticulum Isolation Kit. The levels of α-syn protein and ER-stress-associated downstream chaperones were detected using Western blots and immunofluorescence. Results: Treatment of PC12 cells with tunicamycin (0.5-10 μg/mL) dose-dependently increased the accumulation of α-syn monomer (19 kDa) and oligomer (55 kDa), and decreased the cell viability. Accumulation of the two forms of α-syn was observed in both the ER and mitochondria with increasing treatment time. Co-treatment with 20c (10 -5 mol/L) significantly increased the viability of tunicamycintreated cells, reduced the level of α-syn protein and suppressed ER stress activation in the cells, evidenced by the reductions in phosphorylation of eIF2α and expression of spliced ATF6 and XBP1. Conclusion: Tunicamycin treatment caused accumulation of α-syn monomer and oligomer in PC12 cells. Bibenzyl compound 20c reduces the accumulation of α-syn and inhibits the activation of ER stress, which protected PC12 cells against the toxicity induced by tunicamycin.
Introduction
Parkinson's disease (PD) is an irreversible neurodegenerative disease. Lewy bodies (LBs) and Lewy neuritis (LNs) are the hallmarks of PD pathogenesis [1, 2] . Fibrillar aggregates of ubiquitinated, phosphorylated, and/or S-nitrosylated forms of α-syn are major components of LBs and LNs [3] . Numerous studies have suggested that the accumulation of pathological proteins in the brain is a common characteristic of most neurodegenerative diseases, including PD, Alzheimer's disease (AD), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS) [4] . These neurodegenerative diseases are classified as protein-misfolding disorders (PMDs). Endoplasmic reticulum (ER) dysfunction is suggested to be one of the primary shared characteristics of these disorders [3] . The accumulation of misfolded proteins is sensed by ER resident molecules, which initiate the expression of target genes, impact ER capacity [5] and activate ER stress. Subsequently, a complex signaling pathway to regulate cell responses to ER stress called the unfolded protein response (UPR) is initiated. The initiation of the UPR directly activates three central transmembrane ER signaling chaperones, including PRKP-like ER kinase (PERK), inositol-requiring kinase 1 (IRE1) and activating transcription factor 6 (ATF6). These signaling pathways increase the expression of ER chaperones, inhibit protein entry into ER and accelerate the degradation of retrograde misfolded proteins, which can ameliorate the accumulation of misfolded , Nai-hong CHEN 1, 2, * proteins in the ER [6, 7] . The activation of the PERK pathway promotes the phosphorylation of eIF2α and the expression of transcription factor ATF4, which increases the expression of ER chaperones to reduce protein entry into the ER. During ER stress, ATF6 translocates to the Golgi and releases transcription factors to migrate into the nucleus and regulate gene expression. When IRE1 is activated, it catalyzes the splicing of the mRNA encoding the X-box-binding protein 1 (XBP1) to produce XBP1 and regulate target genes [8] . Although the mechanisms of PD pathogenesis remain unclear, many studies have indicated that the accumulation of α-syn may be a neurotoxic factor [9, 10] . However, the mechanisms underlying α-syn accumulation and how α-syn accumulation contributes to neurodegeneration remain poorly understood. Studies have indicated that sodium butyrate, which is an ER stress inducer, can induce an increase in the oligomeric forms of α-syn in 3D5 cells, and this effect was blocked by cotreatment with the ER stress inhibitor salubrinal, which suggested that ER stress could promote the aggregation of α-syn in 3D5 cells [1] . However, whether ER stress is neurotoxic to PC12 cells is still unknown. Furthermore, the impact of ER stress on the accumulation of the monomeric and oligomeric forms of α-syn and the location of α-syn during ER stress remain unclear.
Gastrodia elata (Tian ma) is a traditional herb that is used to treat headaches, hypertension and neurodegenerative diseases. Recent studies have found that treatment with this herb can enhance cognitive function and help prevent oxidation [11] [12] [13] . The compound 20c (2-[4-hydroxy-3-(4-hydroxybenzyl)-4-(4-hydroxybenzyl) phenol) ( Figure 3C ) was isolated from Gastrodia elata and is a novel bibenzyl compound. Based on previous data from our laboratory, 20c can protect PC12 cells against damage induced by rotenone, which suggests that 20c is a compound with potential neuroprotective effects against PD (data not shown). However, the impact of 20c on the accumulation of α-syn has yet to be determined, and no evidence has been reported that reveals the impact of 20c on the activation of ER stress.
In this study, our data suggest that tunicamycin, which is an ER stress inducer, increased the expression of the monomeric and oligomeric forms of α-syn and that these impacts were associated with the tunicamycin concentration and treatment time. Furthermore, the accumulation of two forms of α-syn in the ER and mitochondria was induced by tunicamycin in a time-dependent manner. 20c reduced the protein level of α-syn and inhibited ER stress by suppressing UPR activation. Together, ER stress increased the accumulation of the monomeric and oligomeric forms of α-syn, and 20c attenuated the damage induced by tunicamycin and promoted PC12 cell survival.
Materials and methods

Reagents
The compound 20c was obtained from the Department of Chemosynthesis, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College (Beijing, China). 20c was dissolved in dimethyl sulfoxide (DMSO) at a concentration of 0.1 mol/L as a stock solution, which was stored at -80 °C until it was used.
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide), tunicamycin, and DMSO were obtained from SigmaAldrich (St Louis, MO, USA). DMEM (Dulbecco's modified Eagle's medium), horse serum (ES) and fetal bovine serum (FBS) were purchased from Gibco (Grand Island, NY, USA). The following primary antibodies were used: anti-α-syn, anticalnexin (1:500, Santa Cruz Biotechnology, Santa Cruz, CA, USA); anti-Grp78, anti-CHOP, anti-p-eIF2α, anti-eIF2α (1:1000, Cell Signaling Technology, Danvers, MA, USA); anti-ATF6 (1:500, Enzo Life Sciences, New York, NY, USA); anti-XBP1, anti-COX4 (1:1000, Abcam, Cambridge, UK); and anti-β-actin (1:5000, Sigma, St Louis, MO, USA). The secondary antibodies were purchased from KPL (1:5000, Gaithersburg, MD, USA).
Cell culture and treatment
Rat pheochromocytoma PC12 cells were maintained in our laboratory. The cells were cultured in DMEM containing 5% FBS and 5% ES and placed in a water-saturated atmosphere of 5% CO 2 at 37 °C. The culture medium was changed every other day. PC12 cells were seeded at a density of 1×10 5 cells· cm -2 .
Tunicamycin [14] was dissolved in DMSO at a concentration of 10 mg/mL as a stock solution. The stock was stored at -80 °C until it was used. The PC12 cells were allowed to attach for 24 h before treatment. Then, the PC12 cells were treated with tunicamycin (0.5, 1, 2, 5, and 10 μg/mL) or treated with tunicamycin (2 μg/mL) and 20c (10 -5 , 10 -6 , and 10 -7 mol/mL) for 24 h. Following the treatment, cell viability assessment, Western blot analysis, and immunofluorescence analysis were performed.
Assessment of cell viability
The cells were treated with tunicamycin or with tunicamycin and 20c for 24 h and cell viability was analyzed using an MTT assay [15] . The cells were seeded in 96-well plates at a density of 5×10 3 cells per well. After treatment for 24 h, 10 μL MTT (5 mg/mL) was added to each well and incubated at 37 °C for 4 h. Then, 100 μL SDS-HCl was added to each well, and the plate was incubated overnight at 37 °C. The optical density (OD) was analyzed at 570 nm on a Microplate Reader (Thermo Skanit Software 3.2, Germany) [16] .
Preparation of the subcellular fraction of the ER and mito chondria PC12 cells were cultured in 10-cm plates at a density of 1×10 5 cells·cm -2 and were treated with tunicamycin (2 μg/mL) for 6, 12, or 24 h. The PC12 cells were collected at 4 °C. The subcellular fractions of the ER and mitochondria were extracted using the Tissue Endoplasmic reticulum Isolation Kit (Genmed Scientific Inc, Netherlands). The collected ER and mitochondria were used for Western blot analysis.
Immunofluorescence Cells were seeded on slides coated with PLL for 24 h. After treatment with tunicamycin (2 μg/mL) for 12, 24, and 48 h, the cells were washed with ice-cold PBS three times for 5 min each time. The cells were fixed with 1% paraformaldehyde and then permeabilized with 0.1% Triton-X 100 for 10 min at room temperature. After washing the cells with PBS three times, the cells were blocked with 5% bovine serum albumin (BSA, Sigma-Aldrich) for 30 min at room temperature and incubated with primary antibodies, including anti-CHOP or anti-α-syn (1:100), overnight at 4 °C. After washing the cells with PBS three times, the cells were incubated with an Alexa Fluor 488-conjugated secondary antibody, an Alexa Fluor 546-conjugated secondary antibody (1:500, Invitrogen, New York, USA) and Hoechst 33342 (1:1000, Life Technologies, NY, USA) for 1 h at room temperature. Images were obtained using a Leica inverted microscope equipped for fluorescence analysis (Leica Microsystems, Germany) [17] .
Western blot analysis
Following the treatments, the cultured medium was removed and cells were harvested in an ice bath. Total proteins were extracted as previously described [17] . PC12 cells were lysed in NP-40 lysis buffer (150 mmol/L NaCl, 1% Nonidet P-40, 50 mmol/L Tris, pH 7.4, and 1 mmol/L ethylenediamine tetraacetic acid) with a proteinase inhibitor cocktail (SigmaAldrich, St Louis, MO, USA). The cell lysates were centrifuged at 12 000×g for 20 min at 4 °C. The supernatant (soluble part) and the precipitant (insoluble part) were collected. The concentration of total protein for each sample was quantified with the Bicinchoninic Acid kit (Pierce, Rockford, IL, USA). Equal amounts of protein were loaded into the SDS-PAGE gels and then transferred to polyvinylidene fluoride (PVDF) membranes (Millipore, Boston, MA, USA). The membranes were blocked with 3% BSA and incubated with different primary antibodies at 4 °C overnight. The membranes were washed with TBST 3 times for 10 min each and incubated with secondary antibodies for 1 h at room temperature. Then, the membranes were washed with TBST three times, and the protein bands were detected with an enhanced chemiluminescence (ECL) plus detection system. The protein bands were analyzed using Gel-Pro Analyzer software (Media Cybernetics, Silver Spring, MD, USA).
Statistical analyses
All data were analyzed using one-way analysis of Variance (ANOVA) with Dunnett's test. The data are shown as the mean±SEM. Differences with P<0.05 were considered statistically significant. All statistical analyses were performed using Prism 5 (GraphPad Software, Inc).
Results
Tunicamycin induced an increase in the monomeric and oligomeric forms of α-syn in PC12 cells Studies have suggested that α-syn pathology can initiate ER stress in α-syn A53T mutant transgenic mice (αA53T tg mice) and that an inhibitor of ER stress, salubrinal, can significantly reduce the accumulation of α-syn in αA53T tg mice [18] . To determine whether an ER stress inducer could be directly associated with the accumulation of α-syn, we treated PC12 cells with tunicamycin at different concentrations (0.5, 1, 2, 5, and 10 μg/mL) for 24 h. The extracted protein was analyzed by Western blot analysis. The two bands, including one at approximately 19 kDa and another at 55 kDa, were the monomeric and oligomeric forms of α-syn. After tunicamycin administration, the protein levels of the monomeric and oligomeric forms of α-syn were increased in a dose-dependent manner in both the soluble and insoluble parts of the protein extracted ( Figure 1A ). Subsequently, we treated the PC12 cells with tunicamycin (2 μg/mL) for 12, 24, and 48 h. The protein level of CHOP increased with the treatment time. Meanwhile, the protein expression of α-syn increased in a time-dependent manner and was co-located with the increase in CHOP ( Figure  1B ). These data suggest that tunicamycin led to the accumulation of the monomeric and oligomeric forms of α-syn and that this accumulation was associated with the concentration and duration of tunicamycin treatment.
Accumulation of α-syn induced by tunicamycin occurred in the ER and mitochondria
Because the accumulation of α-syn was induced by tunicamycin, we identified the disturbance of α-syn in the ER after treating the cells with tunicamycin. First, we extracted the microsome (ER) and mitochondria fractions of PC12 cells ( Figure  2A ) and analyzed the alteration of α-syn using Western blot analysis. Surprisingly, the protein levels of the monomeric form of α-syn in the ER increased in a time-dependent manner after tunicamycin treatment. After 24 h, the oligomeric form of α-syn in the ER increased as well. Additionally, the accumulation of the α-syn monomer and oligomer in mitochondria increased after tunicamycin treatment. After 24 h, the oligomeric form of α-syn had a similar increase in the mitochondria as it did in the ER ( Figure 2B ). All of the data suggest that the monomeric and oligomeric forms of α-syn were enriched in a time-dependent manner in the ER and mitochondria fractions after tunicamycin administration.
20c significantly attenuated the accumulation of α-syn induced by tunicamycin The major component of LBs is α-syn. Numerous data suggest that increased levels of α-syn lead to neurodegeneration. New compounds to ameliorate or prevent the α-synucleinopathies have attracted a great deal of attention [19] . First, we treated PC12 cells with tunicamycin at different concentrations (0.5, 1, 2, 5, and 10 μg/mL) and analyzed cell viability using an MTT assay. Compared to the control group, cell viability decreased according to the concentration of tunicamycin. When the PC12 cells were treated with tunicamycin (2 μg/mL), the cell viability declined to 51.29 % (Figure 3A) . Therefore, 2 μg/mL was used in subsequent tests. Previous data indicated that 20c protected PC12 cells against the neurotoxicity of rotenone. To determine whether 20c attenuated the damage induced by 20c inhibited ER stress by suppressing the UPR The ER is the central intracellular organelle that is responsible for the synthesis, quality control, and degradation of proteins. Because 20c attenuated the increase of α-syn, we speculated that 20c inhibited the activation of ER stress. After treating the PC12 cells with tunicamycin or with tunicamycin and 20c, we analyzed the protein level of Grp78 (a marker of ER stress). Compared with the control group, tunicamycin significantly increased the protein level of Grp78. We found that 20c (10 -5 mol/L) remarkably decreased the expression of Grp78 ( Figure  5 ). To determine the effects of 20c on the activation of UPR, we analyzed the protein levels of ER-stress-associated downstream chaperones. Compared to the control group, the phosphorylation of eIF2α and the expression of transcription factor ATF4 were significantly increased by tunicamycin, which meant that the PERK signaling pathway was activated. We also determined that 20c markedly reduced the phosphorylation of eIF2α and the expression of ATF4 and that 20c inhibited the PERK pathway ( Figure 6A ). Similar to the effects of 20c on the PERK pathway, the activation of the IRE1 and the ATF6 pathways was notably inhibited by 20c and was accompanied by a decrease in the protein levels of XBP1 and ATF6 (50) ( Figure 6B ). These data suggest that 20c suppressed the activation of the major branches of the UPR, which suggests that 20c can inhibit ER stress.
Discussion
The presence of potentially pathogenic protein aggregates is a common characteristic shared by PD and other PMDs [20] . However, whether ER stress directly contributes to the accumulation or aggregation of α-syn has not been clarified. Our data indicate that the accumulation of α-syn is directly induced by an ER stress inducer and that the increase of the monomeric or oligomeric forms of α-syn is associated with the tunicamycin concentration and treatment time. Additionally, the two forms of α-syn accumulated in the ER and mitochon- dria after treatment with tunicamycin, which suggests that ER stress was an active participant in the process of α-syn accumulation. Moreover, our studies provide evidence that 20c exerts protective effects on tunicamycin-treated PC12 cells, reduces the expression of α-syn and inhibits the activation of the UPR, which suggest that 20c is a neuroprotective compound worthy of future study.
The aggregation of α-syn leads to lysosomal dysfunction [21] , membrane disruption [22] , and dopaminergic neuron disorders [20] . Numerous studies have proposed that the aggregation of α-syn or the increased Ser129 phosphorylation of α-syn are co-localized with UPR activation [23, 24] . ER stress initiates the UPR to modulate cellular response to restore ER homeostasis. The UPR leads to the simultaneous activation of adaptive and pro-apoptotic responses [25] . Under chronic ER stress, when the ER homeostasis fails to be recovered, the UPR triggers cell death through apoptosis [3] . The ER-stress-associated apoptosis pathway is the central pathway for eliminating damaged cells. The best characteristic of the pro-apoptotic pathway is the production of the CHOP transcription factor, which is modulated by ATF4, and possibly by ATF6 and XBP1 [26, 27] . In our studies, tunicamycin increased the expression of α-syn in a timedependent manner. Accompanied by enhancement of the ERstress intensity, the viability of PC12 cells was reduced. That decrease in viability is the reason why, after 48 h of tunicamycin treatment, the number of cells in the image was less than other groups. On the other hand, 20c attenuated the decrease in cell viability induced by tunicamycin, which indicated that 20c could protect against ER-stress-associated insults. Caspase-12-caspase-3 is another ER-stress-associated apoptosis pathway. Caspase-12 can be specifically cleaved and activated after the activation of the IRE1 pathway [28] . The effects of 20c on the activation of caspase-12 have yet to be clarified.
The accumulation of α-syn in the ER due to tunicamycin treatment is consistent with recent studies suggesting that α-syn accumulates in the ER as PD progresses [1] . The level of α-syn in the ER of presymptomatic αA53T tg mice was proportional to the total α-syn. Subsequently, higher molecular [29, 30] . Moreover, the overexpression of α-syn in yeast blocked ER-Golgi vesicular trafficking, which contributed to toxicity, cell loss and selective impacts on dopamineproducing neurons [19] . Furthermore, α-syn disrupts UPR by interacting with ATF6 and blocking the incorporation of ATF6 into COPII vesicles [31] . These studies indicate that the accumulation of α-syn may trigger the activation of ER stress. Furthermore, the accumulation of α-syn in the mitochondria was induced after treatment with tunicamycin. Bir et al observed that the intracellular accumulation of α-syn in SHSY5Y cells led to mitochondrial impairment and cell death through interaction with the permeability transition pore complex in isolated preparations [32] . Moreover, monomers and oligomers of α-syn A53T localized to the mitochondrial membranes, and this localization was associated with selective age-related mitochondrial complex I inhibition, which suggested that mitochondrial α-syn affects cells and led to mitochondria dysfunction [33] . The impact of 20c on the expression of α-syn in the ER and mitochondria should be further studied.
Based on the current studies and our data supporting a relationship between ER-stress-associated toxicity and the accumulation of α-syn, we propose a model ( Figure 7A ). Normally, α-syn is located in the lumen of ER. Upon stimulation by tunicamycin or other stimuli, the monomeric form of α-syn increases and aggregates into the oligomeric form of α-syn. Finally, the oligomeric form matures into insoluble aggregates as the disease progresses. The accumulation or aggregation of α-syn triggers the activation of ER stress, and chronic ER stress leads to the initiation of ER-stress-associated apoptosis. As feedback, ER dysfunction exacerbates the increase in α-syn expression. Given the therapeutic effects of salubrinal on reducing α-syn oligomers in the ER [1] , the abnormal accumulation of α-syn contributes to chronic ER stress and ER-stressassociated insults.
Current pharmacological therapies for PD only attenuate the symptoms and fail to prevent the progression of PD [15] . Therefore, new therapeutic compounds should be very attractive to researchers. Previous studies in our laboratory provide evidence that 20c protected against neurotoxicity in H 2 O 2 -and rotenone-treated models. Based on the model that we have proposed, 20c attenuated the accumulation of α-syn, which alleviated the activation of UPR by suppressing all three central downstream pathways. As a result, 20c improved cell viability, which was decreased by tunicamycin ( Figure  7B ). However, the mechanism through which 20c decreased the expression of α-syn has yet to be determined. Numerous pathological conditions trigger ER stress and result in cell death, including disturbance of ER Ca 2+ homeostasis, ER-Golgi vesicular trafficking, and local oxidative stress [5, 34] . Compound 20c was observed to be an anti-oxidative compound. The next step would be to identify the mechanism of protection that 20c exerts against the toxicity induced by tunicamycin and to determine whether 20c attenuates the accumulation and inhibits the initiation of UPR through anti-oxidative effects and modulation of ER Ca 2+ homeostasis. Together, the data obtained in our studies suggest that tunicamycin treatment led to neurotoxicity, decreased cell viability, and increased the accumulation of the monomeric and oligomeric forms of α-syn. Additionally, tunicamycin promoted the accumulation of two forms of α-syn in the ER and mitochondria in a time-dependent manner. Furthermore, 20c reduced the accumulation of α-syn and inhibited the initiation of UPR. The data indicate that modulation of ER stress is involved in the neuroprotective action of 20c. We therefore 
